ATC code G02

ATC code G02 Other gynecologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup G02 is part of the anatomical group G Genito-urinary system and sex hormones.[4]

ATC codes
G Genito-urinary system and sex hormones
G01 Gynecological antiinfectives and antiseptics
G02 Other gynecologicals
G03 Sex hormones and modulators of the genital system
G04 Urologicals
ATCvet only
QG51 Antiinfectives and antiseptics for intrauterine use
QG52 Products for teats and udder

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QG02.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

G02A Uterotonics

G02AB Ergot alkaloids

G02AB01 Methylergometrine
G02AB02 Ergot alkaloids
G02AB03 Ergometrine
QG02AB53 Ergometrine, combinations

G02AC Ergot alkaloids and oxytocin including analogues, in combination

G02AC01 Methylergometrine and oxytocin
QG02AC90 Ergometrine and oxytocin

G02AD Prostaglandins

G02AD01 Dinoprost
G02AD02 Dinoprostone
G02AD03 Gemeprost
G02AD04 Carboprost
G02AD05 Sulprostone
G02AD06 Misoprostol
QG02AD90 Cloprostenol
QG02AD91 Luprostiol
QG02AD92 Fenprostalene
QG02AD93 Tiaprost
QG02AD94 Alfaprostol
QG02AD95 Etiproston

G02B Contraceptives for topical use

G02BA Intrauterine contraceptives

G02BA01 Plastic IUD
G02BA02 Plastic IUD with copper
G02BA03 Plastic IUD with progestogen

G02BB Intravaginal contraceptives

G02BB01 Vaginal ring with progestogen and estrogen
G02BB02 Vaginal ring with progestogen

G02C Other gynecologicals

G02CA Sympathomimetics, labour repressants

G02CA01 Ritodrine
G02CA02 Buphenine
G02CA03 Fenoterol
QG02CA90 Vetrabutin
QG02CA91 Clenbuterol

G02CB Prolactin inhibitors

G02CB01 Bromocriptine
G02CB02 Lisuride
G02CB03 Cabergoline
G02CB04 Quinagolide
G02CB05 Metergoline
G02CB06 Terguride

G02CC Anti-inflammatory products for vaginal administration

G02CC01 Ibuprofen
G02CC02 Naproxen
G02CC03 Benzydamine
G02CC04 Flunoxaprofen

G02CX Other gynecologicals

G02CX01 Atosiban
G02CX02 Flibanserin
G02CX03 Agni casti fructus
G02CX04 Cimicifugae rhizoma
G02CX05 Bremelanotide
QG02CX90 Denaverine
QG02CX91 Lotrifen

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code G02". WHO Collaborating Centre for Drug Statistics Methodology.
  5. "ATCvet Index 2022: code QG02". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.